We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Warning Letter Roundup: Variety of GMP Repeat Violations Garner FDA Warnings
Warning Letter Roundup: Variety of GMP Repeat Violations Garner FDA Warnings
Significant GMP violations and repeating problems at U.S. companies across the drug supply chain lead the FDA to issue warning letters, including a lack of product testing at an Oklahoma drug manufacturer.